domperidone has been researched along with Ewing Sarcoma in 1 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casteels-Van Daele, M | 1 |
| Dobosz-Cyklis, R | 1 |
| Van de Casseye, W | 1 |
| Verbeeck, P | 1 |
| Wijndaele, L | 1 |
1 other study available for domperidone and Ewing Sarcoma
| Article | Year |
|---|---|
Refusal of further cancer chemotherapy due to antiemetic drug.
Topics: Antineoplastic Agents; Child; Domperidone; Drug Therapy, Combination; Dystonia; Female; Humans; Pati | 1984 |